
¹®Á¤ÈÞ ´ëÇ¥¿øÀå
ÀÇÇйڻç /¾È°úÀü¹®ÀÇ / ½Ã·Â±³Á¤,¼ºÇü¾È°ú Àü¹®ÀÇ
¡¤ ¹®¾È°ú ´ëÇ¥¿øÀ塤 °æÈñ´ëÇб³ Àǰú´ëÇÐ ÀÇÇйڻç
¡¤ îñ)´ëÇѾȰúÇÐȸ ºÎȸÀå
¡¤ îñ)¼ö¿ø½ÃÀÇ»çȸ ȸÀå
¡¤ îñ)°æÈñÀÇ´ë ¾È°úÇб³½Çµ¿¹®È¸Àå
¡¤ îñ)µ¿¼ö¿øº´¿ø ¾È°ú°úÀå
¡¤ 1990³â ±¹³» ¶ó½Ä¼ö¼ú µµÀÔ 1¼¼´ë - ½Ã·Â±³Á¤¼ú Áýµµ ÃÑ6¸¸°Ç
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾ç¾È°úÇÐȸ °ø·Î»ó ¼ö»ó
ÁÖ¿äÇØ¿Ü ¿¬¼ö ¹× ÇÐȸ¹ßÇ¥
¡¤ 1991 USA Anaheim ¹Ì±¹¾È°úÇÐȸ¡¤ 1992 USA Sanfrancisco ¹Ì±¹¾È°úÇÐȸ
¡¤ 1994 USA Atlanta ¹Ì±¹¾È°úÇÐȸ
¡¤ 1995 Deutch Achen University ¿¬¼ö
¡¤ 1996 USA Seattle ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 1997 USA Boston ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 2002 Greece À¯·´±¼Àý¼ö¼úÇÐȸ
¡¤ 2007 USA SanDiego ¹Ì±¹±¼Àý¼ö¼úÇÐȸ
¡¤ 2009 USA Sanfrancisco ¹Ì±¹¾È°úÇÐȸ
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇÑ ¾È°úÇÐȸ Á¤È¸¿ø¡¤ ´ëÇÑ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹ ¾È°úÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹ ¹é³»Àå ±¼Àý¼ö¼úÇÐȸ Á¤È¸¿ø
¡¤ ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ½É»çÀ§¿ø

Á¶°üÇõ ¿øÀå(¸Á¸·¼¾ÅÍÀå)
ÀÇÇйڻç/¾È°úÀü¹®ÀÇ/ ¸Á¸·Àü¹®ÀÇ/ Çѱ¹¸Á¸·ÇÐȸÁ¤È¸¿ø
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ¡¤ ºÐ´ç¼¿ï´ëÇб³º´¿ø ¸Á¸·ÀüÀÓÀÇ
¡¤ ÀÇ·á¹ýÀÎ Çѱæ¾È°úº´¿ø ¸Á¸·¼¾ÅÍ °úÀå (°¡Å縯°üµ¿ÀÇ´ë±³¼ö)
¡¤ ¹Ì±¹ÀÇ»çÀÚ°Ý Ãëµæ (USMLE,New York State, United States)
¡¤ ¹Ì±¹ ´º¿å Ä÷³ºñ¾Æ Àǰú´ëÇÐ ¾È°ú¿¬¼ö(Columbia University Medical Center, Edward S. Harkness Eye Institute, New York)
¡¤ ¸¶¸£ÄûÁî ÈĽºÈÄ (Marquis Who¡¯s Who) - ¼¼°è3´ëÀθí»çÀü, ÀÇÇоȰúºÐ¾ßµîÀç
¡¤ û¿Í´ë Àǹ«½Ç ±ºÀǰü (¼öµµ¹æÀ§»ç·ÉºÎ)
¡¤ 2016 ´ëÇѾȰúÇÐȸ Çмú»ó/2017 ¾Æ½Ã¾ÆÅÂÆò¾ç¸Á¸·ÇÐȸ ¿ì¼ö¿¬±¸ÀÚ»ó (APVRS)
¼Ò¼ÓÇÐȸ
¡¤ Çѱ¹¸Á¸·ÇÐȸ º¸ÇèÀ§¿ø / ¼ö¿ø½ÃÀÇ»çȸ Àǹ«À̻硤 ´ëÇѾȰúÇÐȸ / Çѱ¹Æ÷µµ¸·ÇÐȸ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ(AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸(ARVO) Á¤È¸¿ø
¡¤ ¼ö¿ø½Ã ¾Æµ¿ÀÇ·áÁö¿ø»ç¾÷ ºÎÀ§¿øÀå
ÁÖ¿äÇÐȸ¹ßÇ¥
¡¤ 2014ARVO in Orlando / 2015 AAO in Las Vegas¡¤ 2016 ARVO in Seattle / 2016 AAO in Chicago
¡¤ 2017 ASCRS in Los Angeles / 2017 APVRS in Kuala Lumpur
ÁÖ¿ä³í¹® : (SCI ³í¹® 1ÀúÀÚ¸¸ ±â¼ú, Àü¼¼°è Top 3 ¾È°ú³í¹® 10¿©Æí, ¸ñ·Ï÷ºÎ)
¡¤ ¸Á¸·³»Ãþ ºÒ±ÔÄ¢ Áö¼ö¸¦ ÀÌ¿ëÇÑ ¸Á¸·Àü¸·ÀÇ ¿¹ÈÄ ¿¹Ãø - ¹Ì±¹¾È°úÀú³Î(AJO) 2016¡¤ ¸Á¸·µ¿¸ÆÆó¼â ȯÀÚÀÇ Ç÷Àü ¾ç»ó ºÐ¼® - ¹Ì±¹¾È°úÀú³Î(AJO) 2016
¡¤ ¸Á¸·ºÐÁöÁ¤¸ÆÆó¼â ȯÀÚÀÇ ³úÇ÷°ü ³ªÀÌ ºÐ¼® - ¹Ì±¹½Ã°úÇÐÇÐȸÀú³Î(IOVS) 201
¡¤ ¸Á¸·¹Ú¸® ȯÀÚÀÇ ¼ú ÈÄ ±¼Àý°ª º¯È - ¹Ì±¹¾È°úÀú³Î(AJO) 2014
ÃÖ±Ù SCI ³í¹® ¸ñ·Ï (Á¦ 1ÀúÀÚ¸¸ ±âÀç)
1. Cho KH, Park SJ, Cho JH, Woo SJ, Park KH. Inner-retinal Irregularity Index Predicts Postoperative Visual Prognosis in Idiopathic Epiretinal Membrane. Am J Ophthalmol. 2016 Aug;168:139-49 2. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. Ischemic Injury of the Papillomacular Bundle Is a Predictive Marker of Poor Vision in Eyes with Branch Retinal Artery Occlusion. Am J Ophthalmol. 2016 Feb;162:107-120 3. Cho KH, Park IW, Kwon SI. Changes in postoperative refractive outcomes following combined phacoemulsification and pars plana vitrectomy for rhegmatogenous retinal detachment. Am J Ophthalmol. 2014 Aug;158(2):251-256 4. Cho KH, Park SJ, Woo SJ, Park KH. Correlation between Inner-retinal changes and outer-retinal damage in patients with idiopathic epiretinal membrane. Retina 2017 Oct 23. 5. Cho KH, Ahn SJ, Jung C, Han MK, Park KH, Woo SJ. The characteristics of retinal emboli and its association with vascular reperfusion in retinal artery occlusion. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4589-98 6. Cho KH, Kim CK, Woo SJ, Park KH, Park SJ. Cerebral Small Vessel Disease in Branch Retinal Artery Occlusion. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5818-5824. 7. Cho KH, Kim CK, Oh K, Oh SW, Park KH, Park SJ. Retinal Vein Occlusion as the Surrogate Marker for Premature Brain Aging in Young Patients. Invest Ophthalmol Vis Sci. 2017 May 1;58(6). 8. Cho KH, Kim J, Choi DG, Lee JY. Do the primary surgical option for basic-type exotropia cause differences in distance-near discrepancy of recurrent exotropia after surgery? PLoS One. 2019 Aug 19;14(8) 9. Cho KH, Kim HW, Choi DG, Lee JY. Type of the recurrent exotropia after bilateral rectus recession for intermittent exotropia. BMC Ophthalmol. 2016 Jul 8;16:97 10. Cho KH, Lee JY Correction of Hypertropia Coexisting with Intermittent Exotropia, J Korean Ophthalmol Soc 2014;55(12):1883-1889 11. Cho KH, Lee MJ A Case of Canaliculocele Treated with Punctoplasty and Marsupialization J Korean Ophthalmol Soc 2014;55(6):898-901
ÀÌ¸í¿ø ¿øÀå(³ì³»Àå¼¾ÅÍÀå)
¾È°úÀü¹®ÀÇ / ³ì³»Àå Àü¹®ÀÇ/ Çѱ¹³ì³»ÀåÇÐȸÁ¤È¸¿ø
¡¤ »ï¼ºÀÇ·á¿ø »ï¼º¼¿ïº´¿ø ³ì³»Àå Àü¹®ÀÇ¡¤ ´Ü±¹ÀÇ´ë ´Ü±¹´ëÇб³º´¿ø ¾È°ú ³ì³»Àå ±³¼ö
¡¤ ÀϺ» ±¸¸¶¸ðÅä ±¹¸³´ëÇÐ ³ì³»Àå ¿¬¼ö (Kumamoto Univ. Hospital Glaucoma center)
¡¤ ¸¶¸£ÄûÁîÈĽºÈÄ (Marquis Who¡¯s Who) - ¼¼°è 3´ë Àθí»çÀü, ÀÇÇÐ ¾È°úºÐ¾ß µîÀç
¼Ò¼ÓÇÐȸ
¡¤ ¹Ì±¹¾È°úÇÐȸ (AAO) / ¹Ì±¹½Ã°úÇבּ¸È¸ (ARVO) Á¤È¸¿ø¡¤ À¯·´³ì³»ÀåÇÐȸ(EGS) /¼¼°è³ì³»ÀåÇùȸ(WGA) Á¤È¸¿ø
¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹³ì³»ÀåÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹½Å°æ¾È°úÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ Á¤È¸¿ø
ÁÖ¿äÇÐȸ¹ßÇ¥
¡¤ 2014 ARVO in Orlando (¹Ì±¹½Ã°úÇבּ¸È¸)¡¤ 2015 AAO in Las Vegas (¹Ì±¹¾È°úÇÐȸ)
¡¤ 2016 ARVO in Seattle (¹Ì±¹½Ã°úÇבּ¸È¸)
¡¤ 2016 AAO in Chicago (¹Ì±¹¾È°úÇÐȸ)
¡¤ 2017 WGC in Finland (¼¼°è³ì³»ÀåÇÐȸ)
¡¤ 2019 WGC in Melbourne (¼¼°è³ì³»ÀåÇÐȸ)
ÁÖ¿ä³í¹®(SCI 1ÀúÀÚ)
1. Initial central scotomas vs peripheral scotomas in normal-tension glaucoma: clinical characteristics and progression rates. Eye (Lond). 2014 Mar;28(3):303-11.2. Therapeutic Effect of Steroids in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy. J Korean Ophthalmol Soc 2017;58(10):1176-82
3. Comparative analysis of mean retinal thickness measured using SD-OCT in normal young or old age and glaucomatous eyes. Int Ophthalmol. 2018 Dec;38(6):2417-2426
4. Short-term Effects and Safety of an acute increase of intraocular pressure after Intravitreal Bevacizumab injection on Corneal Endothelial Cells. BMC ophthalmology2018 Jan 25;18(1):17

±è¹Î¼® ¿øÀå
¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ÀÓ»ó°»ç¡¤ ºÐ´ç¼¿ï´ëÇб³º´¿ø ¸Á¸· ÀüÀÓÀÇ
¡¤ ¸ñÆ÷½ÃÀÇ·á¿ø ¾È°ú°úÀå
¡¤ ÀÎÁ¦´ëÇб³ »ó°è¹éº´¿ø ¾È°ú Àü°øÀÇ
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ / Çѱ¹¸Á¸·ÇÐȸ Á¤È¸¿ø¡¤ À¯·´¸Á¸·ÇÐȸ (EURETINA) / ¹Ì±¹½Ã°úÇבּ¸È¸ (ARVO) Á¤È¸¿ø
ÁÖ¿äÇÐȸȰµ¿
¡¤ 2014 EVER in France, Nice¡¤ 2018 APVRS in Korea, Seoul
¡¤ 2019 ARVO in Canada, Vancouver
¡¤ 2019 EURETINA in France, Paris
¡¤ 2019 ´ëÇѾȰúÇÐȸ Ãß°èÇÐȸ ºñµð¿À, ±¸¿¬, Æ÷½ºÅÍ ¹ßÇ¥
ÁÖ¿ä³í¹®: (³í¹® 1ÀúÀÚ)
1. Kim MS, Lee KM, Hwang JM, Yang HK, Woo SJ. Morphologic Features of Buried Optic Disc Drusen on En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. American Journal of Ophthalmology. 2020 May;213:125-133.2. Kim MS, Kim JS, Woo SJ. Toxic crystalline retinopathy due to overdose of intravitreal ganciclovir. JAMA Ophthalmol. 2019 Dec 1;137(12)
3. Kim MS, Jeong HY, Cho KH, Oh SW, Byun SJ, Woo SJ, Yang HK, Hwang JM, Park KH, Kim CK, Park SJ. Nonarteritic anterior ischemic optic neuropathy is associated with cerebral small vessel disease. PLoS One. 2019 Nov 14;14(11)
4. Kim MS, Park SJ, Park KH, Woo SJ. Different mechanistic association of myopia with rhegmatogenous retinal detachment between young and elderly patients. Biomed Res Int. 2019 Aug
5. Kim MS, Joo K, Seong MW, Kim MJ, Park KH, Park SS, Woo SJ. Genetic Mutation Profiles in Korean Patients with Inherited Retinal Diseases. J Korean Med Sci. 2019 Jun
6. Kim MS, Hong HK, Park KH, Woo SJ. Intravitreal Dexamethasone Implant with Plasma Autoantibody Monitoring for Cancer-Associated Retinopathy. Korean J Ophthalmol. 2019 Jun; 33(3): 298-300.
7. Kim MS, Hong HK, Ko YJ, Park KH, Ueno S, Okado S, Woo SJ, Joo K. A case of melanoma-associated retinopathy with autoantibodies against TRPM1. Doc Ophthalmol . 2020 May 29.
8. Kim MS, Park SJ, Joo K, Kang HG, Kim M, Woo SJ. Single-Haptic Dislocation of Retropupillary Iris-Claw Intraocular Lens: Outcomes of Reenclavation. Ophthalmic Surg Lasers Imaging Retina . 2020 Jul 1;51(7):384-390.
9. Kim MS, Ryoo NK, Park KH. Laser and Anti-Vascular Endothelial Growth Factor Treatment for Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration. Scientific Reports. 2020 Sep 1;10(1):14370
10. Kim MS, Cho JH, Byun SJ, Oh CM, Park KH, Park SJ. Increased Risk of Cancer in Patients with Retinal Vein Occlusion: A 12-year Nationwide Cohort Study. British Journal of Ophthalmology. 2020-316947
11. Kim MS, Woo SJ, Park KH. Phacovitrectomy versus lens-sparing vitrectomy for rhegmatogenous retinal detachment repair according to the surgical experience. RETINA. (In press)

¹®¼ö¿µ ¿øÀå
¾È°úÀü¹®ÀÇ / ½Ã·Â±³Á¤Àü¹®ÀÇ
¡¤ ÇѸ²´ëÇб³ ÀÇ·á¿ø ¾È°úÀü¹®ÀÇ¡¤ ÇѸ²´ëÇб³º´¿ø ¾È°úÀü°øÀÇ
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø¡¤ Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(KSCRS) Á¤È¸¿ø
¡¤ ¹Ì±¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(ASCRS) Á¤È¸¿ø
¡¤ Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ Á¤È¸¿ø
¡¤ ´ëÇѰ˾ÈÇÐȸÁ¤È¸¿ø
¡¤ Çѱ¹¿Ü¾ÈºÎÇÐȸ Á¤È¸¿ø
¡¤ ¹Ì±¹¾È°úÇÐȸ (AAO) Á¤È¸¿ø
¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ (ARVO) Á¤È¸¿ø
ÁÖ¿äÇÐȸȰµ¿
¡¤ 2015 AAO (¹Ì±¹¾È°úÇÐȸ) in Las Vegas¡¤ 2016 AAO (¹Ì±¹¾È°úÇÐȸ) in Chicago
¡¤ 2016 ´ëÇѾȰúÇÐȸ Ãß°è ¸Á¸· ±¸¿¬
¡¤ 2018 ´ëÇѾȰúÇÐȸ Ãá°è ¸Á¸· ±¸¿¬ ¹× Æ÷½ºÅÍ ¹ßÇ¥

±è¹ÎÀç ¿øÀå
¾È°úÀü¹®ÀÇ / ¿Ü¾ÈºÎÀü¹®ÀÇ / Çѱ¹¿Ü¾ÈºÎÇÐȸ Á¤È¸¿ø
¡¤ °í·Á´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¿Ü¾ÈºÎÀü¹®ÀÇ¡¤ °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¾È°ú ¿Ü¾ÈºÎ ÀÓ»ó°»ç
¡¤ °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¾È°ú Àü¹®ÀÇ
¡¤ °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¾È°ú Àü°øÀÇ
¡¤ °í·Á´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ Á¤È¸¿ø¡¤ Çѱ¹¿Ü¾ÈºÎÇÐȸ Á¤È¸¿ø
¡¤ Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(KSCRS) Á¤È¸¿ø
¡¤ ¹Ì±¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ(ASCRS) Á¤È¸¿ø
¡¤ Çѱ¹ÄÜÅÃÆ®·»ÁîÇÐȸ Á¤È¸¿ø
ÁÖ¿äÇÐȸȰµ¿
¡¤ 2019 Asia Dry Eye Summit in Kamakura, Japan(¾Æ½Ã¾Æ°Ç¼º¾ÈÇÐȸ)¡¤ 2016 ´ëÇѾȰúÇÐȸ Ãß°è ¹é³»Àå±¼Àý ¹× ¿Ü¾ÈºÎ Æ÷½ºÅÍ ¹ßÇ¥
¡¤ 2017 ´ëÇѾȰúÇÐȸ Ãá°è »ç½Ã¼Ò¾Æ ±¸¿¬ ¹ßÇ¥
¡¤ 2018 ´ëÇѾȰúÇÐȸ Ãá°è ¼ºÇü¾È°ú ±¸¿¬ ¹ßÇ¥

ÃÖÇý¸² ¿øÀå
ÀÇÇм®»ç / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ¡¤ ¼¿ï´ëÇб³º´¿ø ¾È°ú ÀÓ»ó ÀüÀÓ°»ç
¡¤ ¼¿ï´ëÇб³º´¿ø ¾È°ú Àü¹®ÀÇ
¡¤ ¼¿ï´ëÇб³º´¿ø ¼ö·ÃÀÇ
¡¤ ¼¿ï´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ¡¤ Çѱ¹Æ÷µµ¸·ÇÐȸ
¡¤ ¹Ì±¹¾È°úÇÐȸ (AAO)
¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ (ARVO)
ÁÖ¿äÇÐȸȰµ¿
¡¤ 2016 ¹Ì±¹¾È°úÇÐȸ (AAO) in Chicago¡¤ 2017 À¯·´¸Á¸·ÇÐȸ (EURETINA) in Barcelona
¡¤ 2018 À¯·´¹é³»Àå±¼Àý¼ö¼úÇÐȸ (ESCRS) in Vienna
ÁÖ¿ä³í¹® (1ÀúÀÚ)
1. Choe HR, Yang HK, Hwang JM, Long-term outcomes of prismatic correction in partially accommodative esotropia. PLoS One. 2019;14(12):e0225654.2. Choe HR, Park WC, Different types of maculopathy between eyes after a high-voltage electrical shock injury. Case Reports in Ophthalmology 2019;10:19-23.
3. Choe HR, Yoon CH, Kim MK, Transplantation of Circumferentially-trephined Autologous Oral Mucosal Graft on Ocular Surface Reconstruction in patients with Limbal Stem Cell Deficiency. Korean J Ophthalmol 2019;33(1):16-25.
4. Choe HR, Kim NJ, Choung HK. Eyeball Displacement into Ethmoid Sinus with Good Visual Restoration. J Korean Ophthalmol Soc 2016;57(9):1472-1475.

¹ÚÀ¯Á¤ ¿øÀå
ÀÇÇм®»ç / ¾È°úÀü¹®ÀÇ / ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¿Ü·¡±³¼ö¡¤ ¼¿ï¾Æ»êº´¿ø ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¾È°úÇб³½Ç ¸Á¸·Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¾È°ú ÀÓ»ó ÀüÀÓ°»ç
¡¤ ¼¿ï¾Æ»êº´¿ø ¾È°ú Àü¹®ÀÇ
¡¤ ¼¿ï¾Æ»êº´¿ø ¼ö·ÃÀÇ
¡¤ ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¾È°úÇÐ ¼®»ç ¼ö·á
¡¤ ¿ï»ê´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
¼Ò¼ÓÇÐȸ
¡¤ ´ëÇѾȰúÇÐȸ¡¤ ¹Ì±¹½Ã°úÇÐÇÐȸ (ARVO)
ÁÖ¿äÇÐȸ¹ßÇ¥ (1ÀúÀÚ ¹ßÇ¥)
¡¤ 2017 ¹Ì±¹¾È°úÇÐȸ (ARVO) in Baltimore¡¤ 2019 À¯·´¸Á¸·ÇÐȸ (EURETINA) in Paris
¡¤ 2019 ¾Æ½Ã¾Æ-ÅÂÆò¾ç À¯¸®Ã¼ ¸Á¸·ÇÐȸ (APVRS) in Shanghai
ÁÖ¿ä³í¹® (1ÀúÀÚ)
1. Park YJ, Son GS, Lee YJ et al. Intravitreal Anti-vascular Endothelial Growth Factor Injections to Treat Neovascular Age-related Macular Degeneration: Long-term Treatment Outcomes. J Korean Ophthalmol Soc. 2018;59(12):1142-1151